Doctor with Vaccine

States Are Trying To Cap The Price of Insulin. Pharmaceutical Companies Are Pushing Back.

The drug industry has fought some state efforts to make insulin more affordable to people who are on Medicare or lack health insurance.
Tennessee state Rep. Jason Hodges wanted to do something about the soaring cost of insulin. He learned that in the United States, the average list price for insulin tripled from 2002 to 2013 and then doubled from 2012 to 2016, forcing some diabetics to spend as much as $1,200 a month. So he wrote a bill to forbid any pharmacy in Tennessee from charging more than $100 for a 30-day insulin supply, thinking that would force drug companies to lower their prices.